ZA954469B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA954469B
ZA954469B ZA954469A ZA954469A ZA954469B ZA 954469 B ZA954469 B ZA 954469B ZA 954469 A ZA954469 A ZA 954469A ZA 954469 A ZA954469 A ZA 954469A ZA 954469 B ZA954469 B ZA 954469B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA954469A
Inventor
Kott Edna
Kesler Anat
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA954469B publication Critical patent/ZA954469B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
ZA954469A 1994-06-06 1995-05-31 Pharmaceutical compositions ZA954469B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9411292A GB9411292D0 (en) 1994-06-06 1994-06-06 Pharmaceuticals compositions

Publications (1)

Publication Number Publication Date
ZA954469B true ZA954469B (en) 1996-01-24

Family

ID=10756253

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954469A ZA954469B (en) 1994-06-06 1995-05-31 Pharmaceutical compositions

Country Status (8)

Country Link
EP (1) EP0767672A1 (en)
JP (1) JPH10500695A (en)
AU (1) AU2787495A (en)
CA (1) CA2192218A1 (en)
GB (1) GB9411292D0 (en)
IL (1) IL113992A0 (en)
WO (1) WO1995033475A1 (en)
ZA (1) ZA954469B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214791B1 (en) 1997-01-10 2001-04-10 Yeda Research And Development Co. Ltd. Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
ES2527760T3 (en) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Treatment of Crohn's disease with copolymer 1 and polypeptides
EP1098902A4 (en) 1998-07-23 2002-07-24 Yeda Res & Dev Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US7022663B2 (en) 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
JP2003535118A (en) * 2000-06-05 2003-11-25 テバ ファーマシューティカル インダストリーズ リミティド Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Treatment of central nervous system diseases by antibodies against glatiramer acetate
WO2001097785A2 (en) * 2000-06-20 2001-12-27 Caprion Pharmaceuticals Inc. Basic copolymers for the treatment of prion-related-disease
AU2002353059B2 (en) 2001-12-04 2008-06-19 Teva Pharmaceutical Industries, Ltd. Processes for the measurement of the potency of glatiramer acetate
JP5297653B2 (en) 2004-10-29 2013-09-25 サンド・アクチエンゲゼルシヤフト Manufacturing method of glatiramer

Also Published As

Publication number Publication date
EP0767672A1 (en) 1997-04-16
AU2787495A (en) 1996-01-04
WO1995033475A1 (en) 1995-12-14
JPH10500695A (en) 1998-01-20
CA2192218A1 (en) 1995-12-14
IL113992A0 (en) 1995-10-31
GB9411292D0 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
ZA957247B (en) Pharmaceutical compositions
HU9503199D0 (en) Pharmaceutical basic compositions
EG24118A (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
GB2308545A (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
GB9411933D0 (en) Pharmaceutical compositions
GB9406121D0 (en) Pharmaceutical compositions
GB9401872D0 (en) Pharmaceutical compositions
GB9404457D0 (en) Pharmaceutical compositions
GB9405879D0 (en) Pharmaceutical compositions